The 3rd Next Generation Ophthalmic Drug Delivery Summit unites pharma and biotech to accelerate development of delivering long-lasting ophthalmic therapies.
The 3rd Next Generation Ophthalmic Drug Delivery Summit covers topics such as:
- Developing Sustained-Release Degradable Implants to Increase Therapy Duration & Reduce Patient Burden
- Evaluating Non-Degradable Sustained Release Implants to Achieve Robust Delivery Durability
- Revolutionizing Topical Treatments as a Minimally Invasive Method to Deliver Therapies to the Back of the Eye
- Constructing Clinical Trials to Allow Novel Therapies to Compete With the Current Intravitreal Injection Standard of Care
- Gene Therapies: Evaluating Current Advancements in Subretinal Delivery and Exploring Alternative Delivery Routes to Develop Less Invasive Therapies
- Investigating Animal Models for Durable Ophthalmic Therapies to Drive Translation into Clinical Trials
The 3rd Next Generation Ophthalmic Drug Delivery Summit might be held in San Francisco, United States in Jan 2025.
